Interest Expense of Pelthos Therapeutics Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Pelthos Therapeutics Inc. quarterly Interest Expense in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
Pelthos Therapeutics Inc. Interest Expense for the quarter ending 30 Sep 2025 was $1,346,000, a 3351% increase year-over-year.
Source SEC data: View on sec.gov

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Pelthos Therapeutics Inc. Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025		$1,346,000	+$1,307,000	+3351%	01 Jul 2025	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q1 2025		$1,816	+$1,816		01 Jan 2025	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q3 2024		$39,000			01 Jul 2024	30 Sep 2024	10-Q	13 Nov 2025	2025	Q3
Q1 2024		$0			01 Jan 2024	31 Mar 2024	10-Q	13 May 2025	2025	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.